vs
Church & Dwight（CHD）与Encompass Health Corp（EHC）财务数据对比。点击上方公司名可切换其他公司
Church & Dwight的季度营收约是Encompass Health Corp的1.1倍（$1.6B vs $1.5B），Encompass Health Corp净利率更高（9.5% vs 8.7%，领先0.7%），Encompass Health Corp同比增速更快（9.9% vs 3.9%），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs 4.6%）
Church & Dwight是美国知名消费品企业，成立于1847年，总部位于新泽西州尤因。公司主营个人护理、家居用品及特色产品，旗下拥有Arm & Hammer、Trojan、OxiClean等知名品牌，2022年全年营收达54亿美元。
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
CHD vs EHC — 直观对比
营收规模更大
CHD
是对方的1.1倍
$1.5B
营收增速更快
EHC
高出6.0%
3.9%
净利率更高
EHC
高出0.7%
8.7%
两年增速更快
EHC
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.5B |
| 净利润 | $143.5M | $146.1M |
| 毛利率 | 45.8% | — |
| 营业利润率 | 16.2% | 16.7% |
| 净利率 | 8.7% | 9.5% |
| 营收同比 | 3.9% | 9.9% |
| 净利润同比 | -24.2% | 20.8% |
| 每股收益（稀释后） | $0.60 | $1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHDEHC
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.5B | $1.3B |
净利润CHDEHC
| Q4 25 | $143.5M | $146.1M | ||
| Q3 25 | $182.2M | $126.5M | ||
| Q2 25 | $191.0M | $142.1M | ||
| Q1 25 | $220.1M | $151.5M | ||
| Q4 24 | $189.2M | $120.9M | ||
| Q3 24 | $-75.1M | $108.2M | ||
| Q2 24 | $243.5M | $114.1M | ||
| Q1 24 | $227.7M | $112.5M |
毛利率CHDEHC
| Q4 25 | 45.8% | — | ||
| Q3 25 | 45.1% | — | ||
| Q2 25 | 43.0% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 47.1% | — | ||
| Q1 24 | 45.7% | — |
营业利润率CHDEHC
| Q4 25 | 16.2% | 16.7% | ||
| Q3 25 | 16.1% | 14.9% | ||
| Q2 25 | 17.4% | 16.2% | ||
| Q1 25 | 20.1% | 16.4% | ||
| Q4 24 | 16.2% | 14.3% | ||
| Q3 24 | -6.1% | 13.6% | ||
| Q2 24 | 22.3% | 14.3% | ||
| Q1 24 | 20.3% | 13.6% |
净利率CHDEHC
| Q4 25 | 8.7% | 9.5% | ||
| Q3 25 | 11.5% | 8.6% | ||
| Q2 25 | 12.7% | 9.7% | ||
| Q1 25 | 15.0% | 10.4% | ||
| Q4 24 | 12.0% | 8.6% | ||
| Q3 24 | -5.0% | 8.0% | ||
| Q2 24 | 16.1% | 8.8% | ||
| Q1 24 | 15.1% | 8.5% |
每股收益（稀释后）CHDEHC
| Q4 25 | $0.60 | $1.43 | ||
| Q3 25 | $0.75 | $1.24 | ||
| Q2 25 | $0.78 | $1.39 | ||
| Q1 25 | $0.89 | $1.48 | ||
| Q4 24 | $0.76 | $1.18 | ||
| Q3 24 | $-0.31 | $1.06 | ||
| Q2 24 | $0.99 | $1.12 | ||
| Q1 24 | $0.93 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.0M | $72.2M |
| 总债务越低越好 | $2.2B | $2.4B |
| 股东权益账面价值 | $4.0B | $2.4B |
| 总资产 | $8.9B | $7.1B |
| 负债/权益比越低杠杆越低 | 0.55× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资CHDEHC
| Q4 25 | $409.0M | $72.2M | ||
| Q3 25 | $305.3M | $48.7M | ||
| Q2 25 | $923.2M | $99.1M | ||
| Q1 25 | $1.1B | $95.8M | ||
| Q4 24 | $964.1M | $85.4M | ||
| Q3 24 | $752.1M | $147.8M | ||
| Q2 24 | $491.7M | $154.4M | ||
| Q1 24 | $349.7M | $134.4M |
总债务CHDEHC
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.2B | $2.4B | ||
| Q2 25 | $2.2B | $2.3B | ||
| Q1 25 | $2.2B | $2.3B | ||
| Q4 24 | $2.2B | $2.4B | ||
| Q3 24 | $2.2B | $2.3B | ||
| Q2 24 | $2.2B | $2.7B | ||
| Q1 24 | $2.2B | $2.7B |
股东权益CHDEHC
| Q4 25 | $4.0B | $2.4B | ||
| Q3 25 | $4.2B | $2.4B | ||
| Q2 25 | $4.4B | $2.3B | ||
| Q1 25 | $4.6B | $2.2B | ||
| Q4 24 | $4.4B | $2.1B | ||
| Q3 24 | $4.2B | $2.0B | ||
| Q2 24 | $4.3B | $1.8B | ||
| Q1 24 | $4.1B | $1.7B |
总资产CHDEHC
| Q4 25 | $8.9B | $7.1B | ||
| Q3 25 | $9.1B | $6.9B | ||
| Q2 25 | $8.8B | $6.8B | ||
| Q1 25 | $9.0B | $6.6B | ||
| Q4 24 | $8.9B | $6.5B | ||
| Q3 24 | $8.7B | $6.5B | ||
| Q2 24 | $8.8B | $6.4B | ||
| Q1 24 | $8.6B | $6.2B |
负债/权益比CHDEHC
| Q4 25 | 0.55× | 1.00× | ||
| Q3 25 | 0.52× | 1.01× | ||
| Q2 25 | 0.50× | 1.02× | ||
| Q1 25 | 0.48× | 1.08× | ||
| Q4 24 | 0.51× | 1.14× | ||
| Q3 24 | 0.53× | 1.20× | ||
| Q2 24 | 0.51× | 1.46× | ||
| Q1 24 | 0.54× | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $346.0M |
| 自由现金流经营现金流 - 资本支出 | — | $116.7M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | 3.4% | 14.8% |
| 现金转化率经营现金流/净利润 | — | 2.37× |
| 过去12个月自由现金流最近4个季度 | — | $439.2M |
8季度趋势，按日历期对齐
经营现金流CHDEHC
| Q4 25 | — | $346.0M | ||
| Q3 25 | — | $270.8M | ||
| Q2 25 | — | $270.2M | ||
| Q1 25 | — | $288.6M | ||
| Q4 24 | $292.3M | $278.8M | ||
| Q3 24 | $364.0M | $267.8M | ||
| Q2 24 | $236.9M | $217.4M | ||
| Q1 24 | $263.0M | $238.8M |
自由现金流CHDEHC
| Q4 25 | — | $116.7M | ||
| Q3 25 | — | $83.7M | ||
| Q2 25 | — | $113.3M | ||
| Q1 25 | — | $125.5M | ||
| Q4 24 | $237.7M | $80.1M | ||
| Q3 24 | $315.4M | $120.3M | ||
| Q2 24 | $206.6M | $60.5M | ||
| Q1 24 | $216.7M | $99.4M |
自由现金流率CHDEHC
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | 15.0% | 5.7% | ||
| Q3 24 | 20.9% | 8.9% | ||
| Q2 24 | 13.7% | 4.6% | ||
| Q1 24 | 14.4% | 7.6% |
资本支出强度CHDEHC
| Q4 25 | 3.4% | 14.8% | ||
| Q3 25 | 1.8% | 12.7% | ||
| Q2 25 | 1.5% | 10.8% | ||
| Q1 25 | 1.1% | 11.2% | ||
| Q4 24 | 3.5% | 14.1% | ||
| Q3 24 | 3.2% | 10.9% | ||
| Q2 24 | 2.0% | 12.1% | ||
| Q1 24 | 3.1% | 10.6% |
现金转化率CHDEHC
| Q4 25 | — | 2.37× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | 1.54× | 2.31× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | 0.97× | 1.91× | ||
| Q1 24 | 1.16× | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHD
| Household Products | $645.3M | 39% |
| Personal Care Products | $625.9M | 38% |
| Consumer International | $299.8M | 18% |
| Specialty Products Division | $73.2M | 4% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
